147 related articles for article (PubMed ID: 16584506)
21. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
[TBL] [Abstract][Full Text] [Related]
22. Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C.
Hung CH; Lee CM; Chen CH; Hu TH; Jiang SR; Wang JH; Lu SN; Wang PW
Liver Int; 2009 Aug; 29(7):1086-93. PubMed ID: 19302182
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory markers in adults with Prader-Willi syndrome before and during 12 months growth hormone treatment.
Höybye C
Horm Res; 2006; 66(1):27-32. PubMed ID: 16685133
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
25. Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus.
Tso TK; Huang WN; Huang HY; Chang CK
Rheumatology (Oxford); 2006 Sep; 45(9):1148-53. PubMed ID: 16527878
[TBL] [Abstract][Full Text] [Related]
26. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
Schaumberg DA; Glynn RJ; Jenkins AJ; Lyons TJ; Rifai N; Manson JE; Ridker PM; Nathan DM
Circulation; 2005 May; 111(19):2446-53. PubMed ID: 15867184
[TBL] [Abstract][Full Text] [Related]
27. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
[TBL] [Abstract][Full Text] [Related]
28. Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women.
Escobar-Morreale HF; Villuendas G; Botella-Carretero JI; Sancho J; San Millán JL
Diabetologia; 2003 May; 46(5):625-33. PubMed ID: 12739017
[TBL] [Abstract][Full Text] [Related]
29. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
[TBL] [Abstract][Full Text] [Related]
30. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
[TBL] [Abstract][Full Text] [Related]
31. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.
Kim HJ; Kang ES; Kim DJ; Kim SH; Ahn CW; Cha BS; Nam M; Chung CH; Lee KW; Nam CM; Lee HC
Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000
[TBL] [Abstract][Full Text] [Related]
32. The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used.
Marques-Vidal P; Velho S; Waterworth D; Waeber G; von Känel R; Vollenweider P
Eur J Clin Nutr; 2012 Apr; 66(4):426-35. PubMed ID: 21952696
[TBL] [Abstract][Full Text] [Related]
33. Increased levels of tumour necrosis factor-alpha (TNF-alpha) in patients with Type II diabetes mellitus after myocardial infarction are related to endothelial dysfunction.
Nyström T; Nygren A; Sjöholm A
Clin Sci (Lond); 2006 Jun; 110(6):673-81. PubMed ID: 16466346
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
Ahmad J; Ahmned F; Siddiqui MA; Khan AR; Katyal P; Hameed B; Ahmad I
J Assoc Physicians India; 2007 Oct; 55():693-9. PubMed ID: 18173021
[TBL] [Abstract][Full Text] [Related]
35. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivity.
van Tits LJ; Arioglu-Oral E; Sweep CG; Smits P; Stalenhoef AF; Tack CJ
Neth J Med; 2005; 63(7):250-5. PubMed ID: 16093575
[TBL] [Abstract][Full Text] [Related]
37. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES).
Deepa R; Velmurugan K; Arvind K; Sivaram P; Sientay C; Uday S; Mohan V
Metabolism; 2006 Sep; 55(9):1232-8. PubMed ID: 16919544
[TBL] [Abstract][Full Text] [Related]
39. Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.
Im JA; Kim SH; Lee JW; Shim JY; Lee HR; Lee DC
Metabolism; 2006 Nov; 55(11):1546-50. PubMed ID: 17046559
[TBL] [Abstract][Full Text] [Related]
40. Sex-specific, independent associations of insulin resistance with erythrocyte sedimentation rate in apparently healthy subjects.
López-Bermejo A; Hernández-Aguado I; Vera IJ; Recasens M; Esteve E; Casamitjana R; Ricart W; Fernández-Real JM
Thromb Haemost; 2007 Feb; 97(2):240-4. PubMed ID: 17264953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]